1. The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
- Author
-
Waller EA, Roy A, Brumble L, Khoor A, Johnson MM, and Garland JL
- Subjects
- Adult, Amikacin administration & dosage, Biopsy, Clarithromycin administration & dosage, Diagnosis, Differential, Drug Therapy, Combination, Ethambutol administration & dosage, Female, Granuloma diagnosis, Granuloma drug therapy, Granuloma pathology, Humans, Lung pathology, Mycobacterium avium Complex isolation & purification, Mycobacterium avium-intracellulare Infection drug therapy, Mycobacterium avium-intracellulare Infection pathology, Necrosis, Pneumonia, Bacterial drug therapy, Pneumonia, Bacterial pathology, Prednisone administration & dosage, Rifampin administration & dosage, Sputum microbiology, Tomography, X-Ray Computed, Mycobacterium avium-intracellulare Infection diagnosis, Pneumonia, Bacterial diagnosis
- Abstract
Nontuberculous mycobacteria (NTM) are increasingly recognized as important pulmonary pathogens. Mycobacterium avium intracellulare complex (MAC) causes most lung infections due to NTM. Patients with preexisting lung disease or immunodeficiency are at greatest risk for developing MAC infection. The majority of MAC pulmonary cases, however, occur in immunocompetent elderly women in association with nodular infiltrates and bronchiectasis. More recently, pulmonary disease has also been described in immunocompetent patients after exposure to MAC-contaminated hot tubs. We describe a case of aggressive MAC lung disease in a young immunocompetent female patient without preexisting lung disease whose clinical and pathologic characteristics do not fit into any of these categories and may represent a unique manifestation of MAC lung disease.
- Published
- 2006
- Full Text
- View/download PDF